Results

Total Results: 505 records

Showing results for "achieved".

381. Evidence Summary: Vitamin D Deficiency in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/vitamin-d-deficiency-screening
     April 13, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Vitamin D Deficiency in Adults: Screening April 13, 2021 Recommendations made by the USPSTF are independent of the U.S. government. They should not be constr…

382. Archived: Final Evidence Summary: Gestational Diabetes: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary26/gestational-diabetes-screening1
     May 15, 2008 - Compared with the unmonitored group, the glucose-monitored group achieved statistically significantly

383. Archived: Final Evidence Summary: Gestational Diabetes: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary26/gestational-diabetes-screening-2008
     May 15, 2008 - Compared with the unmonitored group, the glucose-monitored group achieved statistically significantly

384. Tjdzc7Rzm3Wzcdhfc4Sjhq (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/TjDzC7rzm3WzCDHFC4sJhQ
     June 01, 2015 - mixed and were characterized by variability in antihypertensive treatments and baseline, target, and achieved

385. Evidence Summary: Lung Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary14/lung-cancer-screening
     March 09, 2021 - A post hoc analysis of NLST data reported that 88% of the benefit (lung cancer deaths averted) was achieved

386. Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ph_fauqHQjmrSqPAWKrARA
     September 28, 2021 - incidence of pre- eclampsia (18% and 23%),30,46 but several studies using clinical risk factors alone achieved

387. Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/KdQef_VDT2kmHDX4ddNWmR
     August 01, 2022 - Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement Screening for Latent Tuberculosis Infection in Adults US Preventive Services Task Force Recommendation Statement US Preventive Services Task Force Summary of Recommendation See the Summary of Recommenda…

388. Evidence Summary: Statins for Prevention of Cardiovascular Disease in Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication
     November 13, 2016 - Evidence Summary: Statins for Prevention of Cardiovascular Disease in Adults Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication November 13, 2016 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official po…

389. Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/vw-LTWCTZ_N5pAaydcNQTx
     June 21, 2016 - Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the USPSTF Copyright 2016 American Medical Association. All rights reserved. Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies Modeling Study for the US Preventive Services Task F…

390. Archived: Evidence Summary: Statins for Prevention of Cardiovascular Disease in Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication-november-2016
     November 13, 2016 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary: Statins for Prevention of Cardiovascular Disease in Adults Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medicati…

391. Draft Recommendation: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/osteoporosis-screening-prevent-fractures
     June 11, 2024 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Draft Recommendation Statement Osteoporosis to Prevent Fractures: Screening June 11, 2024 Recommendations made by the USPSTF are independent of the U.S. go…

392. High-Priority Evidence Gaps For Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/rtc2016rev_2%20(3).pdf
     December 01, 2016 - High-Priority Evidence Gaps For Clinical Preventive Services DECEMBER 2016 High-Priority Evidence Gaps For Clinical Preventive Services SUBMITTED BY: Dr. Kirsten Bibbins-Domingo, Chair Dr. David C. Grossman, Vice Chair Dr. Susan J. Curry, Vice Chair ON BEHALF OF THE U.S. PREVENTIVE SERVICES TASK FORCE SIXTH AN…

393. Treatment: Evidence Summary: Gestational Diabetes Mellitus, Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/treatment-evidence-summary/gestational-diabetes-mellitus-screening
     May 28, 2013 - Treatment: Evidence Summary Gestational Diabetes Mellitus, Screening May 28, 2013 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Servi…

394. Archived: Chlamydia and Gonorrhea: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/chlamydia-and-gonorrhea-screening-september-2014
     September 22, 2014 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Chlamydia and Gonorrhea: Screening September 22, 2014 Recommendations made by the USPSTF are independent of the U.S. government. The…

395. Recommendation: Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/cardiovascular-disease-screening-using-nontraditional-risk-assessment
     July 10, 2018 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Recommendation Statement Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors July 10, 2018 Recommendations made by the USPSTF are independent …

396. Archived: Treatment: Evidence Summary: Gestational Diabetes Mellitus, Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/treatment-evidence-summary/gestational-diabetes-mellitus-screening-january-2014
     May 28, 2013 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Treatment: Evidence Summary Gestational Diabetes Mellitus, Screening May 28, 2013 Recommendations made by the USPSTF are independent of the U.S. government. They…

397. Archived: Evidence Summary: Aspirin: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication
     March 15, 2007 - mortality with chemoprevention would have to be great enough to compete with the 21% mortality reduction achieved

398. The Use of Aspirin for Primary Prevention of Colorectal Cancer: A Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/pnyU5fxhdBUtCdvJ3GyqzR
     March 01, 2007 - Internal Medicine Volume 146 • Number 5 365 great enough to compete with the 21% mortality reduction achieved

399. Archived: Evidence Summary: Aspirin: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
     March 15, 2007 - mortality with chemoprevention would have to be great enough to compete with the 21% mortality reduction achieved

400. Use of Decision Models in the Development of Evidence-Based Clinical Preventive Services Recommendations (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/decision-modeling-for-uspstf_0.pdf
     July 01, 2016 - Use of Decision Models in the Development of Evidence-Based Clinical Preventive Services Recommendations Use of Decision Models in the Development of Evidence-Based Clinical Preventive Services Recommendations: Methods of the U.S. Preventive Services Task Force Douglas K. Owens, MD, MS; Evelyn P. Whitlock, MD, MPH; J…